- Areas of Interest
- Techniques
- Systems
- Products & Services
- Informatics
- Science & Education
- Company
- Support
Researchers are performing WGS and WES to identify variants associated with lupus and other autoimmune disorders.
Read Article
TruSight Tumor 170 accurately identifies diffuse glioma genetic markers, supporting use in tumor characterization for clinical research studies.
Read Article
Families of children with an undiagnosed disease often face years-long diagnostic odysseys. Hear from health care providers and families who...
View VideoLearn what Q scores mean and why they’re important for any sequencing run
Learn MoreVisit us at booth 1801 and change the way you think about prenatal screening
Learn MoreIllumina offers webinars and free online training courses to get the most out of your experiments and products
View Webinars View CoursesTake your research further with the right sequencing panels or microarrays for your project
Find the Right Product
This collaboration is the first to introduce the concept of rWGS in China for indiscriminate detection in the NICU
Read Article| Date | Publication | Title |
|---|---|---|
| 27-Feb-2019 | Bloomberg | A $100 Genome Within Reach, Illumina CEO Asks If World Is Ready |
| 27-Feb-2019 | Slate | Why Are We So Afraid of Each New Advance in Reproductive Technology? |
| 19-Feb-2019 | San Diego Union Tribune | San Diego biotech company teams up with doctors to offer genome sequencing to Tijuana children |